Perrigo logo

PerrigoNYSE: PRGO

Profile

Sector:

Healthcare

Country:

Ireland

IPO:

17 December 1991

Next earnings report:

07 November 2024

Last dividends:

30 August 2024

Next dividends:

29 November 2024
$3.49 B
-45%vs. 3y high
86%vs. sector
-vs. 3y high
-vs. sector
-37%vs. 3y high
35%vs. sector
-49%vs. 3y high
20%vs. sector

Price

after hours | Fri, 01 Nov 2024 21:30:01 GMT
$25.58+$0.53(+2.12%)
$1.07 B$1.13 B
$1.07 B-$108.40 M

Analysts recommendations

Institutional Ownership

PRGO Latest News

Perrigo Announces Quarterly Dividend
prnewswire.com01 November 2024 Sentiment: POSITIVE

DUBLIN , Nov. 1, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0.276 per share, payable on December 17, 2024, to shareholders of record on November 29, 2024. About Perrigo   Perrigo Company plc (NYSE: PRGO) is a leading provider of Consumer Self-Care Products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed.

Perrigo to Release Third Quarter 2024 Financial Results on November 6, 2024
prnewswire.com23 October 2024 Sentiment: POSITIVE

DUBLIN , Oct. 23, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its third quarter 2024 financial results on Wednesday, November 6, 2024, and host a conference call beginning at 8:30 A.M. (EST). The earnings conference call will be available live via webcast to interested parties in the investor relations section of the Perrigo website at http://perrigo.investorroom.com/events-webcasts or by phone at 800-836-8184, International 646-357-8785, and reference ID # 96443.

PERRIGO ANNOUNCES THE CLOSING OF A SENIOR NOTES OFFERING BY ITS FINANCE SUBSIDIARY, PERRIGO FINANCE UNLIMITED COMPANY
prnewswire.com17 September 2024 Sentiment: POSITIVE

DUBLIN , Sept. 17, 2024 /PRNewswire/ -- Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO) today announced the closing of a registered public offering by Perrigo Finance Unlimited Company, an indirect wholly-owned finance subsidiary of Perrigo (the "Issuer"), of $715 million aggregate principal amount of the Issuer's 6.125% Senior Notes due 2032 (the "USD Notes") and €350 million aggregate principal amount of the Issuer's 5.375% Senior Notes due 2032 (the "Euro Notes" and together with the USD Notes, the "Notes").

PERRIGO ANNOUNCES THE PRICING OF A SENIOR NOTES OFFERING BY ITS FINANCE SUBSIDIARY, PERRIGO FINANCE UNLIMITED COMPANY
prnewswire.com12 September 2024 Sentiment: POSITIVE

DUBLIN , Sept. 12, 2024 /PRNewswire/ -- Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO) today announced the pricing of a registered public offering by Perrigo Finance Unlimited Company, an indirect wholly-owned finance subsidiary of Perrigo (the "Issuer"), of $715 million aggregate principal amount of the Issuer's 6.125% Senior Notes due 2032 (the "USD Notes") and €350 million aggregate principal amount of the Issuer's 5.375% Senior Notes due 2032 (the "Euro Notes" and together with the USD Notes, the "Notes").

Perrigo Appoints Industry Veteran, Charles Atkinson, as Executive Vice President, General Counsel and Secretary
prnewswire.com04 September 2024 Sentiment: POSITIVE

Atkinson joins Perrigo from Haleon plc, where he previously served as Interim General Counsel DUBLIN , Sept. 4, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced the appointment of Charles Atkinson as Executive Vice President, General Counsel and Secretary.

Perrigo to Attend the Piper Sandler Growth Frontiers Conference
prnewswire.com27 August 2024 Sentiment: POSITIVE

DUBLIN , Aug. 27, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to present at the Piper Sandler Growth Frontiers Conference on Tuesday, September 10 at 10:00 AM CDT.  Interested parties can access the webcast on the Perrigo website at http://perrigo.investorroom.com/events-webcasts.

Perrigo Appoints David Ball to the Newly Created Position of Executive Vice President and Chief Brand and Digital Officer
prnewswire.com19 August 2024 Sentiment: POSITIVE

DUBLIN , Aug. 19, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced the appointment of Dr. David Ball as Executive Vice President and Chief Brand and Digital Officer. In this newly created position, Dr. Ball will be responsible for an enterprise-wide marketing strategy that incorporates deep understanding of consumer needs and translates those into winning brand strategies, tactics, and actions.

Perrigo is voluntarily recalling 16,500 cans of baby formula because of high levels of Vitamin D
marketwatch.com09 August 2024 Sentiment: NEGATIVE

Perrigo Co. Plc PRGO, +0.54% said Friday it's voluntarily recalling 16,500 cans of store brand Premium Infant Formula with iron milk-based powder because of levels of Vitamin D that exceed permitted levels. The Dublin-based provider of self-care and over-the-counter health and wellness products said the cans were shipped to H-E-B Grocery Company LP in Texas, and to CVS Health stores in Texas, Florida, California, South Carolina, Virginia, Indiana, Tennessee, New Jersey, Michigan, Pennsylvania, Rhode Island and Missouri.

Perrigo recalls 16,500 cans of its infant formula
reuters.com09 August 2024 Sentiment: NEGATIVE

Perrigo has initiated a voluntary recall of three lots within one batch, or 16,500 cans, of its infant formula sold at H-E-B Grocery Company and CVS , a regulatory filing showed on Friday.

Perrigo (PRGO) Beats on Q2 Earnings, Lags Sales, Cuts View
zacks.com02 August 2024 Sentiment: NEUTRAL

Perrigo (PRGO) reports mixed second-quarter 2024 results. It cuts total net sales forecasts primarily due to expected lower distribution in U.S. store brand in second-half 2024.

What type of business is Perrigo?

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

What sector is Perrigo in?

Perrigo is in the Healthcare sector

What industry is Perrigo in?

Perrigo is in the Drug Manufacturers - Specialty & Generic industry

What country is Perrigo from?

Perrigo is headquartered in Ireland

When did Perrigo go public?

Perrigo initial public offering (IPO) was on 17 December 1991

What is Perrigo website?

https://www.perrigo.com

Is Perrigo in the S&P 500?

No, Perrigo is not included in the S&P 500 index

Is Perrigo in the NASDAQ 100?

No, Perrigo is not included in the NASDAQ 100 index

Is Perrigo in the Dow Jones?

No, Perrigo is not included in the Dow Jones index

When was Perrigo the previous earnings report?

No data

When does Perrigo earnings report?

The next expected earnings date for Perrigo is 07 November 2024